Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial
Arlene Odelia Siefker-Radtke, Nobuaki Matsubara, S.H. Park, Robert Anthony Huddart, Earle Frederick Burgess, Mustafa Özgüroğlu and 24 more
- Rank
- 33 of 3,639
- Percentile
- top 1%
- Where
- Annals of Oncology, 2023
- Citations
- 87
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.